Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Operating Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹1,195 Cr₹1,635 Cr₹2,320 Cr₹2,084 Cr₹1,698 Cr

What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?

The latest Operating Profit ratio of GLENMARK PHARMACEUTICALS is ₹1,195 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹1,195 Cr
Mar2024₹1,635 Cr
Mar2023₹2,320 Cr
Mar2022₹2,084 Cr
Mar2021₹1,698 Cr

How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?

Years Operating Profit % Change
Mar2025 ₹1,195 Cr
-26.89
Mar2024 ₹1,635 Cr
-29.53
Mar2023 ₹2,320 Cr
11.32
Mar2022 ₹2,084 Cr
22.75
Mar2021 ₹1,698 Cr -

Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,456.9 Cr -0.3% 1.8% 34.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -3.5% -6.4% -2.6% Stock Analytics
DIVIS LABORATORIES ₹165,492.0 Cr -5.8% -1.6% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,013.0 Cr 1.4% 7% 23.7% Stock Analytics
CIPLA ₹112,922.0 Cr -4.7% -6.8% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,115.0 Cr -2.8% -8.1% -11.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.3%

1.8%

34.3%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses